JP2015526389A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015526389A5 JP2015526389A5 JP2015515983A JP2015515983A JP2015526389A5 JP 2015526389 A5 JP2015526389 A5 JP 2015526389A5 JP 2015515983 A JP2015515983 A JP 2015515983A JP 2015515983 A JP2015515983 A JP 2015515983A JP 2015526389 A5 JP2015526389 A5 JP 2015526389A5
- Authority
- JP
- Japan
- Prior art keywords
- base pair
- lactic acid
- lactobacillus reuteri
- genome
- prevention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261689338P | 2012-06-04 | 2012-06-04 | |
| US61/689,338 | 2012-06-04 | ||
| PCT/SE2013/050646 WO2013184064A1 (en) | 2012-06-04 | 2013-06-04 | Selection and use of lactic acid bacteria preventing bone loss in mammals |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015526389A JP2015526389A (ja) | 2015-09-10 |
| JP2015526389A5 true JP2015526389A5 (enExample) | 2016-07-14 |
| JP6193981B2 JP6193981B2 (ja) | 2017-09-06 |
Family
ID=49712339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015515983A Active JP6193981B2 (ja) | 2012-06-04 | 2013-06-04 | 哺乳動物における骨量減少を予防する乳酸菌の選択及び使用 |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US20150150917A1 (enExample) |
| EP (2) | EP2854826B9 (enExample) |
| JP (1) | JP6193981B2 (enExample) |
| KR (2) | KR102191537B1 (enExample) |
| CN (1) | CN104755091B (enExample) |
| AU (2) | AU2013272330B2 (enExample) |
| CA (1) | CA2875841C (enExample) |
| DK (2) | DK3456334T3 (enExample) |
| ES (2) | ES2847424T3 (enExample) |
| HR (1) | HRP20190162T1 (enExample) |
| HU (1) | HUE042643T2 (enExample) |
| LT (1) | LT2854826T (enExample) |
| PL (2) | PL2854826T3 (enExample) |
| SI (1) | SI2854826T1 (enExample) |
| TR (1) | TR201901771T4 (enExample) |
| WO (1) | WO2013184064A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101915904B1 (ko) | 2016-08-12 | 2018-11-06 | 한국식품연구원 | 락토바실러스 인테스티날리스를 포함하는 갱년기 예방 또는 치료용 조성물 |
| KR102120479B1 (ko) * | 2018-10-30 | 2020-06-09 | 주식회사 종근당바이오 | 프로바이오틱스를 유효 성분으로 포함하는 이차성 골다공증의 예방 또는 치료용 조성물 |
| US12427174B2 (en) * | 2019-02-05 | 2025-09-30 | Biomedit, Inc. | Probiotic compositions comprising lactobacillus reuteri strains and methods of use |
| KR102080498B1 (ko) * | 2019-08-23 | 2020-02-24 | 정영옥 | 페룰산 및 유산균을 유효성분으로 포함하는 골감소증 개선 또는 예방용 식품 조성물 |
| JP7596301B2 (ja) * | 2019-12-02 | 2024-12-09 | 雪印メグミルク株式会社 | 骨強化剤 |
| CN111718903A (zh) * | 2020-06-24 | 2020-09-29 | 江南大学 | 一种筛选可预防和/或治疗骨质疏松的药物的方法 |
| CN114711429B (zh) * | 2021-06-08 | 2023-11-17 | 青岛蔚蓝生物股份有限公司 | 一株具有增强骨健康作用的罗伊氏乳杆菌及其应用 |
| CN114634901B (zh) * | 2022-05-18 | 2022-08-30 | 微康益生菌(苏州)股份有限公司 | 一种促进骨骼健康的干酪乳杆菌lc16及其培养方法与应用 |
| KR102937770B1 (ko) * | 2023-08-09 | 2026-03-12 | 국립한국교통대학교산학협력단 | 골다공증 억제 균주 및 이의 용도 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1511502A2 (en) * | 2002-06-13 | 2005-03-09 | Alimentary Health Limited | Probiotic therapies using lactobacillus reuteri |
| US7344867B2 (en) * | 2005-04-15 | 2008-03-18 | Eamonn Connolly | Selection and use of lactic acid bacteria for reducing inflammation in mammals |
| EP1918373B1 (en) * | 2005-07-26 | 2014-08-20 | Nestec S.A. | Anti-obesity agent and anti-obesity food |
| WO2008028300A1 (en) * | 2006-09-07 | 2008-03-13 | Mcgill University | Oral polymeric membrane feruloyl esterase producing bacteria formulation |
| US20080254011A1 (en) * | 2007-04-11 | 2008-10-16 | Peter Rothschild | Use of selected lactic acid bacteria for reducing atherosclerosis |
-
2013
- 2013-06-04 HU HUE13800449A patent/HUE042643T2/hu unknown
- 2013-06-04 DK DK18202594.0T patent/DK3456334T3/da active
- 2013-06-04 CA CA2875841A patent/CA2875841C/en active Active
- 2013-06-04 EP EP13800449.4A patent/EP2854826B9/en active Active
- 2013-06-04 LT LTEP13800449.4T patent/LT2854826T/lt unknown
- 2013-06-04 PL PL13800449T patent/PL2854826T3/pl unknown
- 2013-06-04 SI SI201331342T patent/SI2854826T1/sl unknown
- 2013-06-04 WO PCT/SE2013/050646 patent/WO2013184064A1/en not_active Ceased
- 2013-06-04 HR HRP20190162TT patent/HRP20190162T1/hr unknown
- 2013-06-04 US US14/405,496 patent/US20150150917A1/en not_active Abandoned
- 2013-06-04 AU AU2013272330A patent/AU2013272330B2/en not_active Ceased
- 2013-06-04 DK DK13800449.4T patent/DK2854826T3/en active
- 2013-06-04 KR KR1020207011037A patent/KR102191537B1/ko active Active
- 2013-06-04 TR TR2019/01771T patent/TR201901771T4/tr unknown
- 2013-06-04 PL PL18202594T patent/PL3456334T3/pl unknown
- 2013-06-04 CN CN201380029676.7A patent/CN104755091B/zh not_active Expired - Fee Related
- 2013-06-04 EP EP18202594.0A patent/EP3456334B1/en active Active
- 2013-06-04 JP JP2015515983A patent/JP6193981B2/ja active Active
- 2013-06-04 ES ES18202594T patent/ES2847424T3/es active Active
- 2013-06-04 ES ES13800449T patent/ES2711427T3/es active Active
- 2013-06-04 KR KR1020147036636A patent/KR20150028968A/ko not_active Ceased
-
2016
- 2016-10-21 US US15/331,346 patent/US9968643B2/en active Active
-
2018
- 2018-01-23 AU AU2018200524A patent/AU2018200524B2/en not_active Ceased
- 2018-03-12 US US15/918,207 patent/US10232001B2/en active Active
-
2019
- 2019-01-23 US US16/254,994 patent/US10537598B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nader-Macías et al. | Profiles and technological requirements of urogenital probiotics | |
| Cawood et al. | Systematic review and meta-analysis of the effects of high protein oral nutritional supplements | |
| WO2015138357A3 (en) | Compositions useful in treatment of otc deficency | |
| Edel et al. | Stability of bioactives in flaxseed and flaxseed-fortified foods | |
| NZ759766A (en) | Use of lactic acid bacteria to treat or prevent at least one of postnatal depression and postnatal anxiety | |
| HK1218836A1 (zh) | 协同细菌组合物和其制造方法和用途 | |
| BR112013016690A2 (pt) | agente para induzir a produção de ifn, agente imunopotencializador, agente para prevenção ou tratamento de infecção viral, produto comestível ou bebível, método de triagem de bactérias do ácido lático, microrganismo hospedeiro para uma vacina recombinante | |
| WO2015044292A8 (en) | Gene therapy compositions for use in the prevention and/or treatment of non-alcoholic fatty liver disease | |
| JP2017006120A5 (enExample) | ||
| JP2015511821A5 (enExample) | ||
| WO2019066577A3 (ko) | 짧은 사슬 지방산 생성 장내 세균 군집의 변화를 이용한 알코올성 간 질환의 진단 및 치료용 조성물 | |
| NZ628385A (en) | Batches of recombinant adenovirus with altered terminal ends | |
| JP6193981B2 (ja) | 哺乳動物における骨量減少を予防する乳酸菌の選択及び使用 | |
| JP2020520916A5 (enExample) | ||
| CN107405369A8 (zh) | 包含细菌的组合物及将其用于治疗和/或预防胃肠道疾病、代谢疾病和/或其它疾病的方法 | |
| MY187060A (en) | Bifidobacteria as probiotic foundation species of gut microbiota | |
| RU2013114313A (ru) | Противокариесные композиции и пробиотики/пребиотики | |
| JP2014504857A5 (enExample) | ||
| MY178445A (en) | Novel antibody binding to tfpi and composition comprising the same | |
| MY150931A (en) | Substituted oxazolidinones and their use | |
| MY197917A (en) | Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus | |
| ZA200908583B (en) | Substituted (oxazolidinon-5-yl-methyl)-2-thiophene-carboxamides and use thereof in the field of blood coagulation | |
| IN2014DN09240A (enExample) | ||
| Savin et al. | Draft genome sequence of a clinical strain of Yersinia enterocolitica (IP10393) of bioserotype 4/O: 3 from France | |
| Smirnova et al. | Microevolution of cholera agent in the modern period |